Blood screening for west nile virus: the cost-effectiveness of a real-time, trigger-based strategy.
Previous studies have demonstrated that universal blood screening for West Nile virus is not cost-effective. A newly proposed, real-time, trigger-based screening strategy was analyzed and was also shown to be not cost-effective. These results were highly sensitive to pricing of screening assays.
Korves
Caroline T
CT
Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA. ck2187@columbia.edu
Goldie
Sue J
SJ
Murray
Megan B
MB
D003362:Cost-Benefit Analysis; D006801:Humans; D008403:Mass Screening / Q000191:economics*; D014901:West Nile Fever / Q000175:diagnosis*; D014902:West Nile virus / Q000302:isolation & purification*